---
figid: PMC3983565__nihms570991f4
figtitle: MAPK signalling cooperates with loss of APC to promote adenoma development
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC3983565
filename: nihms570991f4.jpg
figlink: /pmc/articles/PMC3983565/figure/F4/
number: F4
caption: 'MAPK signalling cooperates with loss of APC to promote adenoma development.
  The tumour suppressive function of APC lies in its ability to bind β-catenin, leading
  to phosphorylation of β-catenin by GSK3β and its subsequent degradation. Activation
  of the MAPK/ERK pathway can mediate β-catenin stabilization through ERK-mediated
  inhibition of GSK3β. Stabilized β-catenin primarily mediates its oncogenic effects
  through transcriptional activation of target genes such as MYC. Pro-oncogenic MYC
  is vital for APC-mediated tumorigenesis. ERK can further drive tumour formation
  in the context of APC loss by stabilizing Myc though post-translational modifications.
  Abbreviations: MEK, mitogen-activated protein kinase kinase; ERK, extracellular
  signal-regulated kinase; EGFR, epidermal growth factor receptor; APC, adenomatous
  polyposis coli; GSK3β, Glycogen synthase kinase-3 beta; Axin, axis inhibition protein.'
papertitle: Paradoxical oncogenesis and the long term consequences of BRAF inhibition
  in melanoma.
reftext: Geoffrey T. Gibney, et al. Nat Rev Clin Oncol. ;10(7):390-399.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9748743
figid_alias: PMC3983565__F4
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC3983565__F4
ndex: 845049eb-dec1-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3983565__nihms570991f4.html
  '@type': Dataset
  description: 'MAPK signalling cooperates with loss of APC to promote adenoma development.
    The tumour suppressive function of APC lies in its ability to bind β-catenin,
    leading to phosphorylation of β-catenin by GSK3β and its subsequent degradation.
    Activation of the MAPK/ERK pathway can mediate β-catenin stabilization through
    ERK-mediated inhibition of GSK3β. Stabilized β-catenin primarily mediates its
    oncogenic effects through transcriptional activation of target genes such as MYC.
    Pro-oncogenic MYC is vital for APC-mediated tumorigenesis. ERK can further drive
    tumour formation in the context of APC loss by stabilizing Myc though post-translational
    modifications. Abbreviations: MEK, mitogen-activated protein kinase kinase; ERK,
    extracellular signal-regulated kinase; EGFR, epidermal growth factor receptor;
    APC, adenomatous polyposis coli; GSK3β, Glycogen synthase kinase-3 beta; Axin,
    axis inhibition protein.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - ras
  - Hras
  - Kras
  - Rem1
  - Ctnnb1
  - Raf1
  - Axin1
  - Apc
  - Mdk
  - Gsk3b
  - Pt
  - Ephb2
  - Mapk1
  - Bmf
  - Bcl2l11
  - Ccnd1
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EGFR
  - KRAS
  - HRAS
  - NRAS
  - CTNNB1
  - RAF1
  - AXIN1
  - AXIN2
  - APC
  - PROC
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - GSK3B
  - MYC
  - EPHB2
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - BMF
  - BCL2L11
  - CCND1
  - Cancer
---
